ORIGINAL
PAPER
Public Health Focus
Prevalence, Awareness, Treatment, and Control of Hypertension in Lebanon Dany Matar, MD, MPH;1,2 Antonio H. Frangieh, MD, MPH;1,2 Samah Abouassi, MD, MPH;1,2 Fernand Bteich, MD;1 Aline Saleh, PharmD;3 Elie Salame, MD;1 Roland Kassab, MD;1,2 Rabih R. Azar, MD, MPH1,2 From the Division of Cardiology, Faculty of Medicine, Hotel Dieu de France Hospital, St Joseph University, Beirut, Lebanon;1 Middle Eastern Cardiovascular Institute for Research and Education, Beirut, Lebanon;2 and Sanofi, Beirut, Lebanon3
The prevalence and factors related to hypertension (HTN) treatment and control are well investigated in the Western world but remain poorly understood in the Middle East and in middle-income countries such as Lebanon. In order to measure the prevalence, awareness, treatment, and control rates of HTN in Lebanon, the authors measured blood pressure (BP) in 1697 adults. The prevalence of optimal BP (
PAPER
Public Health Focus
Prevalence, Awareness, Treatment, and Control of Hypertension in Lebanon Dany Matar, MD, MPH;1,2 Antonio H. Frangieh, MD, MPH;1,2 Samah Abouassi, MD, MPH;1,2 Fernand Bteich, MD;1 Aline Saleh, PharmD;3 Elie Salame, MD;1 Roland Kassab, MD;1,2 Rabih R. Azar, MD, MPH1,2 From the Division of Cardiology, Faculty of Medicine, Hotel Dieu de France Hospital, St Joseph University, Beirut, Lebanon;1 Middle Eastern Cardiovascular Institute for Research and Education, Beirut, Lebanon;2 and Sanofi, Beirut, Lebanon3
The prevalence and factors related to hypertension (HTN) treatment and control are well investigated in the Western world but remain poorly understood in the Middle East and in middle-income countries such as Lebanon. In order to measure the prevalence, awareness, treatment, and control rates of HTN in Lebanon, the authors measured blood pressure (BP) in 1697 adults. The prevalence of optimal BP (
